NL8201512A - Farmaceutische verpakking voor de behandeling van menopauzesymptomen bij de vrouw, alsmede werkwijze voor de behandeling van menopauzesymptomen. - Google Patents

Farmaceutische verpakking voor de behandeling van menopauzesymptomen bij de vrouw, alsmede werkwijze voor de behandeling van menopauzesymptomen. Download PDF

Info

Publication number
NL8201512A
NL8201512A NL8201512A NL8201512A NL8201512A NL 8201512 A NL8201512 A NL 8201512A NL 8201512 A NL8201512 A NL 8201512A NL 8201512 A NL8201512 A NL 8201512A NL 8201512 A NL8201512 A NL 8201512A
Authority
NL
Netherlands
Prior art keywords
estrone
equivalent effect
amount sufficient
days
norethisterone
Prior art date
Application number
NL8201512A
Other languages
English (en)
Dutch (nl)
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NL8201512A publication Critical patent/NL8201512A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL8201512A 1981-04-09 1982-04-08 Farmaceutische verpakking voor de behandeling van menopauzesymptomen bij de vrouw, alsmede werkwijze voor de behandeling van menopauzesymptomen. NL8201512A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/252,518 US4425339A (en) 1981-04-09 1981-04-09 Treatment of menopausal symptoms
US25251881 1981-04-09

Publications (1)

Publication Number Publication Date
NL8201512A true NL8201512A (nl) 1982-11-01

Family

ID=22956353

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8201512A NL8201512A (nl) 1981-04-09 1982-04-08 Farmaceutische verpakking voor de behandeling van menopauzesymptomen bij de vrouw, alsmede werkwijze voor de behandeling van menopauzesymptomen.

Country Status (6)

Country Link
US (1) US4425339A (fr)
BE (1) BE892801A (fr)
DE (1) DE3213248A1 (fr)
FR (1) FR2503562B1 (fr)
GB (1) GB2096462B (fr)
NL (1) NL8201512A (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4962098A (en) * 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0559240B1 (fr) * 1987-09-24 2001-12-05 Jencap Research Limited Packages contraceptives contenant de l'estrogen et du progestin
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
US5783571A (en) * 1991-01-07 1998-07-21 Pherin Corporation Method of altering hypothalamic function by nasal administration of estrene steroids
CZ297860B6 (cs) * 1993-01-19 2007-04-18 Endorecherche Inc. Pouzití prekursoru pohlavního steroidu pro prípravu farmaceutického prostredku
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
HUT74171A (en) * 1993-06-15 1996-11-28 Pherin Corp Estrene steroids as neurochemical initiators of change in human hypothalamic function and pharmaceutical compositions containing them
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
WO2001046040A1 (fr) 1999-12-20 2001-06-28 Merck & Co., Inc. Plaquette alveolaire pour carte de traitement pharmaceutique
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20030004145A1 (en) 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
CA2480814A1 (fr) * 2002-04-05 2003-10-23 Merck & Co., Inc. Procede d'inhibition de resorption osseuse a l'aide d'une formulation a base d'alendronate et de vitamine d
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US20040259851A1 (en) * 2003-04-11 2004-12-23 Leonard Thomas W. Methods of administering estrogens and progestins
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
WO2006084082A1 (fr) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
US3608075A (en) 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3932635A (en) 1972-04-24 1976-01-13 Syntex Corporation Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4145416A (en) 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances

Also Published As

Publication number Publication date
GB2096462B (en) 1984-06-27
BE892801A (fr) 1982-10-08
US4425339A (en) 1984-01-10
DE3213248A1 (de) 1982-11-04
FR2503562B1 (fr) 1985-07-12
GB2096462A (en) 1982-10-20
FR2503562A1 (fr) 1982-10-15

Similar Documents

Publication Publication Date Title
NL8201512A (nl) Farmaceutische verpakking voor de behandeling van menopauzesymptomen bij de vrouw, alsmede werkwijze voor de behandeling van menopauzesymptomen.
RU2091069C1 (ru) Средство для гормональной контрацепции, подавляющее овуляцию
DE4344405C2 (de) Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
US4390531A (en) Method of contraception using peak progestogen dosage
US7538099B1 (en) Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses
EP0835114B1 (fr) Preparation pharmaceutique combinee, necessaire et methode de contraception orale
EP0253607B2 (fr) Forme de dosage combinée pour des femmes pré-ménopausiques
AU630334B2 (en) Hormone preparations for hormone replacement therapy and contraceptive method
US6500814B1 (en) Hormonal contraceptive
DK175317B1 (da) Anvendelse af et progestogen og et östrogen til fremstilling af et terapeutisk produkt til hormonbehandling af postmenopausale lidelser hos kvinder samt et sådant terapeutisk produkt
DE4308406C1 (de) Kombinationspräparat zur Kontrazeption
EP0868188B1 (fr) Kit a usage contraceptif pour mammiferes femelles, constitue d'une combinaison de gestagene et d'oestrogene
SK286169B6 (sk) Použitie konjugovaných estrogénov a medroxyprogesterón acetátu, farmaceutický prostriedok, farmaceutická dávková jednotka a farmaceutický balíček
DE60203929T2 (de) Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
HU9602657D0 (en) Combined hormonal contraception pharmaceutical preparation
US3502772A (en) Method for stimulating anovulatory cycles and pharmaceutical packages
US7704983B1 (en) Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
JPH07509454A (ja) ホルモン避妊のための排卵抑止剤
DK0871453T3 (da) Farmaceutisk kombinationspræparat til hormonal kontraception
Ettinger et al. Low-dosage esterified estrogens opposed by progestin at 6-month intervals
WO1997006807A2 (fr) Preparation contraceptive combinee, trousse le contenant et procede de contraception au moyen de cette preparation
DK174892B1 (da) Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis
NO169322B (no) Befruktningshindrende preparat med synergistisk virkning
DD297327A5 (de) Kontrazeptive zusammensetzung fuer den mann
CA2134961C (fr) Methode et trousses de contraceptifs oraux et de regulation des regles a base d'oestrogene, de progesterone et d'antiprogesterone

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed